Uncategorised - European Medical Journal

1-Hour Glucose Test Effective for Predicting Postpartum Dysglycaemia

1-hour OGTT is more effective and convenient for predicting postpartum dysglycaemia compared to the traditional 2-hour test.

New Biomarker Model May Predict Heart Disease in Childhood Cancer Survivors

Study reveals a protein model to predict cardiomyopathy in childhood cancer survivors, enhancing early detection and intervention.

Semaglutide Before Bariatric Surgery: Not the Weight Loss Boost Expected

New study finds taking weight-loss drug semaglutide before bariatric surgery doesn’t improve overall weight loss or safety outcomes.

New Global Guideline for Diagnosis and Management of Candidiasis

The new guidelines address emerging antifungal resistance, recent taxonomic reclassifications, and gaps in existing treatment recommendations.

Evaluating Selumetinib for Treating Cutaneous Neurofibromas

Although the Skindex-29 assessment indicated an improvement in emotional well-being after the first cycle, there were no significant or lasting changes.

New Oral TYK2 Inhibitor Shows Psoriasis Efficacy

A phase 2 clinical trial has demonstrated that a once-daily oral tyrosine kinase 2 (TYK2) inhibitor significantly improves symptoms in adults with moderate to severe plaque psoriasis, achieving high clearance rates with a safety profile comparable to placebo.

Dupilumab Rapidly Reduces Lichenification in AD

A new analysis of five clinical trials confirms that dupilumab significantly improves lichenification in patients with moderate to severe atopic dermatitis (AD) across all ages and racial backgrounds.

Researchers Reveal the Alarming Long-Term Risks of Steroid Use

Long-term study reveals alarming cardiovascular risks in steroid users, with some heart conditions up to nine times more likely.

Researchers Discover Drivers of Prostate Cancer Evolution

A study of 666 localised prostate tumours identified 223 driver regions, many influenced by structural variations undetectable via targeted sequencing.

Universal Genetic Testing Proposed for Haemoglobinopathy Newborn Screening

Universal genetic testing for haemoglobinopathies can enhance early detection and health equity in newborn screening programmes worldwide.